Imunon, Inc. — Director's Dealing 2018

May 16, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2018-05-15

Reporting Person: Voss Andreas (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-05-15	Celsion Corporation Common Stock	J	6250	$2.24	Acquired	6607	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-05-15	Option to Purchase Celsion Corporation Common Stock	$2.22	A	50000	Acquired	2028-05-15	Celsion Corporation Common Stock (50000)	Direct

Footnotes

F1: The Director received his quarterly fees in restricted shares of Celsion Corporation Common Stock in lieu of cash.

F2: The number of shares issued to the director was calculated by dividing the quarterly fees by the closing stock price of $2.24 on March 31, 2018.

F3: Represents the closing stock price on the option grant date (February 12, 2018) which was subject to the approval of the Celsion Corporation 2018 Stock Incentive Plan at the Annual Meeting of Stockholders held on May 15, 2018.

F4: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant.